Cover Image
市場調查報告書

多重化驗的全球市場預測 ∼2023年:各產品(消耗品、設備)、類型(核酸、蛋白質、細胞)、技術(流式細胞技術、螢光檢測)、用途(研究開發、診斷)、終端用戶、地區

Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 365315
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
多重化驗的全球市場預測 ∼2023年:各產品(消耗品、設備)、類型(核酸、蛋白質、細胞)、技術(流式細胞技術、螢光檢測)、用途(研究開發、診斷)、終端用戶、地區 Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User - Global Forecast to 2023
出版日期: 2018年06月07日 內容資訊: 英文 144 Pages
簡介

全球多重化驗市場,預計從2018年到2023年的調查期間以7.5%的年複合成長率 (CAGR) 發展,擴大到2018年的23億3,000萬美元,2023年達33億5,000萬美元。這個市場的主要成長要素,是勝過搭配診斷的多重化驗的使用,及單一及傳統化驗的多重化驗的優點等。

本報告提供全球多重化驗的市場調查,市場概要,各產品、類型、技術、用途、終端用戶、地區的市場趨勢,市場規模的變化與預測,成長要素、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 北美的多重化驗市場:各用途、各國
  • 多重化驗市場:各產品與服務
  • 地區概要

第5章 多重化驗的全球市場:概要

  • 簡介
  • 市場動態
    • 促進因素
      • 搭配診斷的多重化驗的使用
      • 勝過單一及傳統化驗的優點
    • 阻礙因素
      • 多重化驗設備的高額成本
      • 嚴格的法規與規格
    • 市場機會
      • 分子診斷及蛋白質分析的生物標記的驗證
      • 大量處理及自動系統的需求

第6章 多重化驗的全球市場:各產品與服務

  • 簡介
  • 消耗品
  • 設備
  • 配件
  • 軟體、服務

第7章 多重化驗的全球市場:各類型

  • 簡介
  • 蛋白質為基礎的
    • 平面蛋白質化驗
    • 珠蛋白質化驗
    • 其他
  • 核酸為基礎
    • 平面核酸化驗
    • 珠核酸化驗
    • 其他
  • 細胞為基礎

第8章 多重化驗的全球市場:各技術

  • 簡介
  • 流式細胞術
  • 螢光檢測
  • 發光檢測
  • 多重即時PRC
  • 其他

第9章 多重化驗的全球市場:各用途

  • 簡介
  • 研究開發
    • 藥物研發、開發
    • 生物標記的發現和驗證
  • 臨床診斷
    • 感染疾病
    • 癌症
    • 心血管疾病
    • 自體免疫疾病
    • 神經系統疾病
    • 代謝、內分泌系疾病
    • 其他

第10章 多重化驗的全球市場:各終端用戶

  • 簡介
  • 製藥、生物科技企業
  • 醫院、研究機關
  • 標準檢測設施
  • 其他

第11章 多重化驗的全球市場:地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 競爭環境

  • 概要
  • 市場排行榜分析
  • 競爭情形與趨勢
    • 產品的認證、上市
    • 聯盟、協定、合作
    • 收購

第13章 企業簡介

  • LUMINEX
  • THERMO FISHER SCIENTIFIC
  • ILLUMINA
  • BIO-RAD LABORATORIES
  • QIAGEN
  • ABCAM
  • BECTON DICKINSON AND COMPANY
  • MERCK
  • AGILENT TECHNOLOGIES
  • MESO SCALE DIAGNOSTICS
  • RANDOX LABORATORIES
  • QUANTERIX
  • BIO-TECHNE
  • OLINK
  • SEEGENE

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 4473

"The global multiplex assays market is projected to grow at a CAGR of 7.5%."

The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. However, the high cost of multiplex assay equipment & standardization of immunoassay design and quality control are the major factors expected to restrain market growth.

"The pharmaceutical and biotechnology segment is expected to account for the largest share in 2018."

On the basis of end user, the global multiplex assays market is divided into pharmaceutical and biotechnology companies, hospitals & academic research institutes, reference laboratories, and other end users. In 2018, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increased adoption of multiplex assays in drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.

"North America is expected to account for the largest share of the market in 2018."

By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe. The dominant share of North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

Break-up Profile of Primaries:

  • By Company Type- Tier 1-42%, Tier 2-37% and Tier 3-21%
  • By Designation- C-level-34%, D-level-42% and Others-24%
  • By Region- North America-32%, Europe-30%, Asia Pacific-24%, and RoW-14%

The key players in the multiplex assays market are: Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US).

Research Coverage:

The multiplex assays market in this report is segmented by product & services, type, technology, application, and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the multiplex assays market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global multiplex assays market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global multiplex assays market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for multiplex assays products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global multiplex assays market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global multiplex assays market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. PRIMARY DATA
    • 2.1.1. KEY DATA FROM PRIMARY SOURCES
    • 2.1.2. KEY INDUSTRY INSIGHTS
  • 2.2. SECONDARY DATA
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MULTIPLEX ASSAYS MARKET OVERVIEW
  • 4.2. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2018)
  • 4.3. MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE (2018 VS. 2023)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Use of multiplex assays in companion diagnostics
      • 5.2.1.2. Advantages over singleplex and traditional assays
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High equipment costs
      • 5.2.2.2. Stringent regulations and standards
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing validation of biomarkers in molecular and protein diagnostics
      • 5.2.3.2. Need for high-throughput and automated systems

6. MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
  • 6.3. INSTRUMENTS
  • 6.4. SOFTWARE AND SERVICES

7. MULTIPLEX ASSAYS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. PROTEIN MULTIPLEX ASSAYS
    • 7.2.1. PLANAR PROTEIN ASSAYS
    • 7.2.2. BEAD-BASED PROTEIN ASSAYS
    • 7.2.3. OTHER PROTEIN ASSAYS
  • 7.3. NUCLEIC ACID MULTIPLEX ASSAYS
    • 7.3.1. PLANAR NUCLEIC ACID ASSAYS
    • 7.3.2. BEAD-BASED NUCLEIC ACID ASSAYS
    • 7.3.3. OTHER NUCLEIC ACID ASSAYS
  • 7.4. CELL-BASED MULTIPLEX ASSAYS

8. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. FLOW CYTOMETRY
  • 8.3. FLUORESCENCE DETECTION
  • 8.4. LUMINESCENCE
  • 8.5. MULTIPLEX REAL-TIME PCR
  • 8.6. OTHER TECHNOLOGIES

9. MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH & DEVELOPMENT
    • 9.2.1. DRUG DISCOVERY & DEVELOPMENT
    • 9.2.2. BIOMARKER DISCOVERY & VALIDATION
  • 9.3. CLINICAL DIAGNOSTICS
    • 9.3.1. INFECTIOUS DISEASES
    • 9.3.2. CANCER
    • 9.3.3. CARDIOVASCULAR DISEASES
    • 9.3.4. AUTOIMMUNE DISEASES
    • 9.3.5. NERVOUS SYSTEM DISORDERS
    • 9.3.6. METABOLISM & ENDOCRINOLOGY DISORDERS
    • 9.3.7. OTHER DISEASES

10. MULTIPLEX ASSAYS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. HOSPITALS & RESEARCH INSTITUTES
  • 10.4. REFERENCE LABORATORIES
  • 10.5. OTHER END USERS

11. MULTIPLEX ASSAYS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
    • 11.2.2. CANADA
  • 11.3. EUROPE
  • 11.4. ASIA PACIFIC
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET RANKING ANALYSIS, 2017
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 12.3.2. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 12.3.3. ACQUISITIONS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. LUMINEX
  • 13.2. THERMO FISHER SCIENTIFIC
  • 13.3. ILLUMINA
  • 13.4. BIO-RAD LABORATORIES
  • 13.5. QIAGEN
  • 13.6. ABCAM
  • 13.7. BECTON DICKINSON AND COMPANY
  • 13.8. MERCK
  • 13.9. AGILENT TECHNOLOGIES
  • 13.10. MESO SCALE DIAGNOSTICS
  • 13.11. RANDOX LABORATORIES
  • 13.12. QUANTERIX
  • 13.13. BIO-TECHNE
  • 13.14. OLINK
  • 13.15. SEEGENE

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 2: MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 4: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 9: PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: OTHER PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 19: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 30: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 41: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 55: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIAC DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 58: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 59: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 64: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 65: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 66: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 69: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 70: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 72: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 75: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 77: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 79: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 80: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 82: US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 84: US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 85: US: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 86: CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 87: CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 89: CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 90: CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 94: EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 95: EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 96: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 97: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 99: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 100: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 101: ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 102: ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 104: ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 105: ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: RANK OF COMPANIES IN THE MULTIPLEX ASSAYS MARKET, 2017
  • TABLE 107: PRODUCT LAUNCHES AND APPROVALS, 2015-2018
  • TABLE 108: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015-2018
  • TABLE 109: ACQUISITIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: MULTIPLEX ASSAYS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: MULTIPLEX ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET (2018-2023)
  • FIGURE 12: INCREASING ADOPTION OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS DRIVES THE GROWTH OF THE MARKET
  • FIGURE 13: R&D TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN NORTH AMERICA IN 2018
  • FIGURE 14: CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2023
  • FIGURE 15: APAC WILL BE THE FASTEST-GROWING MARKET FROM 2018 TO 2023
  • FIGURE 16: GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 17: GEOGRAPHIC SNAPSHOT: ASIA PACIFIC IS THE FASTEST-GROWING REGION IN THE GLOBAL MULTIPLEX ASSAYS MARKET
  • FIGURE 18: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS REGISTERED BY LEADING PLAYERS IN THE MULTIPLEX ASSAYS MARKET, 2015-2018
  • FIGURE 21: LUMINEX: COMPANY SNAPSHOT (2017)
  • FIGURE 22: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 23: ILLUMINA: COMPANY SNAPSHOT ( 2017)
  • FIGURE 24: BIO-RAD LABORATORIES: COMPANY SNAPSHOT ( 2017)
  • FIGURE 25: QIAGEN: COMPANY SNAPSHOT ( 2017)
  • FIGURE 26: ABCAM: COMPANY SNAPSHOT (2017)
  • FIGURE 27: BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 28: MERCK: COMPANY SNAPSHOT (2017)
  • FIGURE 29: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
  • FIGURE 30: QUANTERIX: COMPANY SNAPSHOT (2017)
  • FIGURE 31: BIO-TECHNE: COMPANY SNAPSHOT (2017)
  • FIGURE 32: SEEGENE: COMPANY SNAPSHOT ( 2017)
Back to Top